OxyContin epidemic

The OxyContin epidemic began as a crisis rooted in prescription opioids and outgrew the boundaries of pain treatment, becoming a pathway to heroin dependence and a wider public-health emergency. The book traces that evolution through Lee County, Virginia, Roanoke, Virginia, and rural communities where an expanding supply met family silence, fragmented care, and a criminal-justice response that fell unevenly across racial groups. The period’s significance lies in this compounding movement: a prescription crisis became a heroin crisis, and the harms continued into HIV and hepatitis C even as Virginia began building a more coordinated response.

Origins and the Long Warning

In a letter to Purdue Pharma in November 2000, physician Art Van Zee warned that Lee County might be a sentinel area, comparable to San Francisco and New York during the early years of HIV. He could not then know that the OxyContin epidemic would be followed by a heroin epidemic, which would bring further deaths from HIV and hepatitis C. The book uses that warning to connect a local prescription-drug crisis with consequences that unfolded over decades and crossed from one drug supply to another.

The epidemic was not immediately understood as a suburban problem. Before Roanoke’s 2000s heroin incidents drew broader notice, heroin was widely associated with inner-city Black users and treated largely as a matter for police and court reporters. Don Wolthuis, a federal prosecutor, described an earlier group that was small, socially isolated, and difficult for the wider public to see. That invisibility mattered: the crisis could expand in places that did not fit the prevailing image of who used heroin.

By 2012, the author was reporting on heroin as it reached the suburbs around Roanoke, where families were often too ashamed to speak publicly. Five years later, as the book was being completed, most agreed to have their names used. That change in willingness to be identified marks a shift in public disclosure, not an end to the stigma or the crisis.

From Prescriptions to a Growing Heroin Network

The book describes a recurring pattern in which people began with pills, turned to heroin, and sold part of what they bought to finance the next purchase. Users also recruited new customers, who could in turn bring others into the network. The result was a self-reinforcing chain: the need to avoid withdrawal helped turn individual dependence into an expanding market, while each new connection widened the reach of the supply.

Roanoke’s 2006 case involving Clifton “Lite” Lee showed how that network could cross racial and geographic boundaries. A former crack dealer with roots in Philadelphia, Lee saw an opportunity to increase profits by bringing heroin to Roanoke rather than selling only in New Jersey and New York. When police found two suburban teenagers selling to friends, their phones implicated about fifty other young people, many of them students at Hidden Valley High School in an affluent part of Roanoke County. Lee’s organization extended from people selling for money to users who sold to sustain their own use; prosecutors attributed to his network the importation of a thousand bags two or three times a week. He was sentenced to eleven years in prison in 2008.

Heroin supply continued to exploit the connections between large cities and smaller communities. By spring 2013, investigators believed a supplier was moving heroin into Virginia’s I-81 corridor from New York, with young women carrying it on the Chinatown bus in snack containers. In Woodstock, Virginia, the shipments could include 200 grams, compared with at most 20 grams brought by dealers commuting to Baltimore. A year later, federal agents and prosecutors used 15,000 text messages from Ashlyn Kessler’s phone to map a chain from a New Jersey source to dozens of young people in Cave Spring and Hidden Valley. The messages documented practical arrangements and repeated transactions; together, the cases show a supply system sustained by multiple links rather than a single dealer or town.

Families, Shame, and Barriers to Care

In 2012, parents confronting addiction lacked the online groups that later could connect families across the state to share rehabilitation information, coping strategies, and practical support. Robin Roth felt publicly branded as a failed parent and grieved her only child while blaming the young man she held responsible for his death. At a federal sentencing in 2012, she brought a framed portrait of her son, Scott Roth, to the witness stand and addressed the consequences of his death to the man being sentenced. Her experience reflects how grief could be intensified by isolation and by the sense that a child’s addiction was evidence against the family.

Families also encountered the divide between health care and the criminal-justice system. At a Families Anonymous meeting near Hidden Valley, Jamie Waldrop and Drenna Banks met while both were dealing with their sons’ opioid use. Their stories brought into view how families tried to keep loved ones alive while treatment, law enforcement, and drug markets operated in disconnected ways. Shame could keep those gaps out of public view even as people struggling with dependence and their relatives had to navigate them every day.

The stigma extended into recovery settings. Tess Henry had attended twelve-step meetings before, but some participants regarded treatment with buprenorphine as incompatible with being clean. Although Narcotics Anonymous officially accepted medication-assisted treatment, members whom a meeting leader asked to sponsor or mentor her declined. The gap between official policy and the response she encountered made mutual support conditional and exposed a cultural division over whether medication counted as treatment or merely substituted one opioid for another.

In Hidden Valley, affluence did not protect families from addiction, and it could reinforce silence. Janine Underwood told local school-board members and county officials what was happening and sought support for prevention work. The room responded with silence; the school board declined to support the program, and the county provided its usual $2,000. The author also records that Hope Initiative calls frequently concerned heroin use in Hidden Valley and nearby Cave Spring, while police data indicated that the problem there was worse than in less affluent parts of the county. The contrast unsettled the assumption that the crisis belonged elsewhere.

Unequal Responses and the 2017 Turn

The book contrasts public calls to address opioid addiction without relying on arrest with the continued imprisonment of people such as Ronnie Jones for heroin distribution. It describes how the consequences of drug enforcement fell disproportionately on Black and Hispanic people, even as white opioid users who dealt or committed property crimes to stave off withdrawal were more often discussed as people whom arrest could not help. The cited figures underscore that distinction: three-quarters of federal drug offenders were Black or Hispanic, and people of color made up 57 percent of those imprisoned for drug offenses in state systems. The book also notes a different disparity in medical exposure: 2014 data from the Centers for Disease Control and Prevention showed that doctors prescribed painkillers to people of color at lower rates, in part because of distrust that they would misuse them. These patterns complicate any simple account of who was exposed to opioids, who was criminalized, and who was understood as needing care.

In 2017, the Virginia Board of Medicine required doctors to check the state drug-monitoring system each time they issued a prescription, a measure intended to prevent doctor-shopping. The mandate arrived alongside figures showing that Martinsville, Virginia, and Galax had among the highest opioid-prescription rates per person in the country. Virginia’s response was also expanding medication-assisted treatment and pursuing syringe exchange, while tightening some controls on treatment prescribing. A model for that expansion was Highpower, a Suboxone clinic in rural Lebanon, Virginia, established in 2000 by Hughes Melton to serve underserved patients. His wife, Sarah Melton, trained more than 4,000 doctors about opioid risks and reported some prescribers for overprescribing.

The later response did not erase the earlier failures or settle the tension between treating addiction and preventing medication misuse. Instead, it marked a belated effort to address both. The arc from Van Zee’s warning in 2000 to Virginia’s policy changes in 2017 gives the epidemic its historical shape: local signs were visible early, but the consequences widened—from pills to heroin, from private family distress to public-health harms—before institutions began to respond on a comparable scale.